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Abstract In the isolated, jointly perfused small intestine and
liver of rats insulin, infused into the portal vein, induced an
increase in intestinal glucose absorption via hepatoenteral
cholinergic nerves. The possible loss of function of these nerves
due to ethanol-induced neuropathy was investigated with 6 weeks
ethanol-fed rats. Portal insulin or arterial carbachol failed to
increase intestinal glucose absorption but cAMP still did so. The
intact stimulatory effect of cAMP indicated an undisturbed
capacity of the enterocytes. The loss of action of portal insulin
and of arterial carbachol can be explained by the impairment of
the hepatoenteral nerves in line with an ethanol-induced
neuropathy.
z 2000 Federation of European Biochemical Societies.
Key words: Glucose absorption; Ethanol-induced
neuropathy; Cholinergic nerve; Autonomic nervous system
1. Introduction
The mean daily intake of carbohydrates in the western
world amounts to about 300 g. It corresponds to 50% of
the supply of calories [1]. After the digestion of dietary car-
bohydrates, glucose is taken up into the enterocyte from the
intestinal lumen via the sodium-dependent glucose cotrans-
porter 1 (SGLT1) located in the apical membrane and then
released from the enterocyte into the circulation via the so-
dium-independent glucose transporter 2 (GLUT2) expressed
in the basolateral membrane [2,3]. Recently, an acute modu-
lation of intestinal glucose absorption involving a hepatoen-
teral nervous signaling chain could be demonstrated. In the
isolated perfused small intestine and liver of the rat insulin
infused into the portal vein acutely increased intestinal glucose
absorption via the SGLT1 in a dose-dependent manner [4].
This stimulatory e¡ect of portal insulin could be inhibited by
atropine [4] or tetrodotoxin [5] and mimicked by carbachol
[4], all infused into the superior mesenteric artery [4,5]. These
¢ndings constituted evidence for a signaling chain beginning
with the sensing of insulin in the hepatoportal area, continu-
ing with retrograde transmission via hepatoenteral (from liver
to intestine), cholinergic nerves and ending at the absorptive
cells of the intestine.
Chronic alcohol abuse, a world-wide disorder and a sub-
stantial public health problem, is the cause of a variety of
neurologic manifestations [6]. Ethanol neurotoxicity impairs
not only the function of the central but also of the peripheral
nervous system [7,8]. An impaired function of autonomic
nerves due to chronic alcohol abuse in humans has been ob-
served with the sympathetic skin response [9] and the cardio-
vascular system [10]. Also in chronically ethanol-fed rats a
diminished function of sympathetic hepatic nerves [11] and
of the vagus nerve [12] has been reported. The underlying
mechanism is still not fully understood. However, several
studies showed alterations of the membrane lipid composition
with a change in membrane £uidity following chronic ethanol
consumption [13,14]. The clinical importance of an impaired
function of the autonomic nervous system was demonstrated
when chronic male alcoholics were followed up for 7 years;
the percentage survival with no evidence of vagal neuropathy
was 91%. However, with an abnormal function of the vagus
nerve survival was reduced to 66%. Hence, ethanol-induced
vagal neuropathy was associated with a signi¢cantly higher
mortality than in the general population of male alcoholics
[15].
Ethanol-induced hypoglycemia is a common ¢nding in hu-
man and experimental animals [16]. The loss of function of
the hepatoenteral nerves and therefore diminished absorption
of carbohydrates might contribute to the ethanol-induced hy-
poglycemia. Therefore, it was the aim of the current study to
examine a possible functional impairment of the hepatoenteral
nerves, which mediate the insulin-dependent increase in intes-
tinal glucose absorption, in line with an alcohol-induced neu-
ropathy.
2. Materials and methods
2.1. Materials
All chemicals were of reagent grade and from commercial sources.
Enzymes were purchased from Boehringer (Mannheim, Germany),
insulin and carbachol from Sigma (Mu«nchen, Germany), bovine se-
rum albumin, dextran and db-cAMP from AppliChem (Darmstadt,
Germany).
2.2. Animals
Male Wistar rats were obtained from Harlan-Winkelmann (Bor-
chen, Germany). Control rats were weight-matched to the ethanol-
treated rats (about 390 g at the time of the perfusion experiments in
both groups, Table 1); due to the expected decreased growth rate of
ethanol-treated rats initial body weight was 264 þ 24 g in control and
383 þ 18 g in alcohol-fed animals, respectively (Table 1). They were
kept on a 12-h day^night rhythm with free access to food and water
(standard diet of Ssni¡, Soest, Germany). Chronic alcohol feeding was
performed for 6 weeks by adding ethanol to the drinking water with
stepwise increases within 14 days prior to the 6 weeks to a ¢nal
concentration of 20% (v/v) [17]. In addition, to overcome the natural
aversion of rats to ethanol, the drinking water was sweetened by
adding of 0.8 mol/l glucose. Weight of the animals was monitored
daily; consumption of the alcohol and glucose containing drinking
water and corresponding daily intake of ethanol and glucose as well
as the daily intake of laboratory chow were recorded (Table 1). Dur-
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ing the preparation of the joint perfusion of small intestine and liver,
blood was obtained for subsequent determination of the blood etha-
nol and glucose concentration. Treatment of animals followed the
German Law on the Protection of Animals and was performed with
permission of the state animal welfare committee.
2.3. Preparation of the isolated joint perfusion of small intestine and
liver
The joint perfusion of small intestine and liver was prepared as
described before [4,18]. Rats were anaesthetized by an intraperitoneal
injection of pentobarbital (40 g/l in 0.9% NaCl; 60 mg/kg body
weight). The abdomen was opened by a midline incision, the superior
mesenteric artery (SMA) and coeliac trunc (CT) were cannulated and
the inferior vena cava (IVC) opened as out£ow. Thus, a non-recircu-
lating perfusion of intestine and liver was started with a hydrostatic
pressure of 120 cm H2O (i.e. 88 mm Hgw11.77 kPa). Then spleen,
pancreas and proximal half of the stomach were removed after ligat-
ing their arteries and veins. For the luminal application of glucose, a
catheter was positioned in the proximal duodenum. The cecum was
cut open and the small intestine washed out with a warm saline so-
lution. A luminal out£ow was established by placing a catheter
through the cecum into the distal ileum. Afterwards, a cannula for
the vascular out£ow was introduced into the right atrium, the tip
positioned at the in£ow of the hepatic vein into the IVC and ¢xed.
Then, intestine and liver were transferred into an organ bath ¢lled
with a warmed saline solution and two £exible catheters were intro-
duced into the portal vein (PV), one for obtaining medium samples
and the other one for infusion of insulin.
2.4. Determination of vascular £ow
The £ow rate in the SMA was measured with an ultrasound £ow
meter T106 (Transonic Systems Inc., Ithaca, NY, USA). Total £ow in
the IVC was quanti¢ed by fractionating the perfusion e¥uate into
calibrated tubes. The £ow rate in the CT was calculated as the di¡er-
ence between the £ow in the IVC and SMA.
2.5. Perfusion medium, vascular application of e¡ectors and intestinal
bolus
The perfusion medium consisted of a Krebs^Henseleit bu¡er con-
taining 5 mmol/l glucose, 2 mmol/l lactate, 0.2 mmol/l pyruvate,
1 mmol/l glutamine, 1% (w/v) bovine serum albumin and 3% (w/v)
dextran. The perfusion medium was equilibrated with a gas mixture of
O2 :CO2 (19:1). Insulin (¢nal concentration 100 nmol/l), carbachol
(10 Wmol/l) and dibutyryl cAMP (1 Wmol/l) were infused as solutions
in perfusion medium into the vessels as described in the ¢gure legends.
The luminal glucose bolus of 1 g diluted in 1.5 ml 0.9% NaCl was
applied within 1 min via the luminal catheter placed into the duode-
num.
2.6. Determination of glucose and blood ethanol concentrations
Perfusion samples were taken every minute and immediately chilled
on ice. Glucose concentration was measured with standard enzymatic
techniques with glucose dehydrogenase (Merck system) [19]. Before
CT and SMA were cannulated, blood was drawn from the IVC for
subsequent determination of blood alcohol. Ethanol concentration
was measured with the indaniline method with horse liver alcohol
dehydrogenase [20].
2.7. Statistical analysis
All results are presented as means þ S.E.M. for the indicated num-
ber of observations. Data were analyzed by Student’s t-test for un-
paired data. Di¡erences were considered signi¢cant at P6 0.05.
3. Results
3.1. Characterization of control and chronically ethanol-treated
rats
All rats were fed a standard diet. Control rats had free
access to normal drinking water; ethanol-treated rats received
water with alcohol (20%) and glucose (0.8 mmol/l) added.
Following adaptation, ethanol treatment was continued for
6 weeks. Average daily intake during this period was about
9 g ethanol/kg body weight resulting in a blood ethanol con-
centration of about 18 mmol/l (Table 1). Daily ethanol intake
was comparable with previous results obtained with rats fed
the ethanol containing Lieber^DeCarli liquid diet; however,
blood ethanol concentrations reached were somewhat lower
[11,21]. Under this alcohol challenge the growth rate of ani-
mals was substantially retarded; this is in agreement with
previous data showing a reduced growth rate in animals
treated with ethanol in the drinking water [22^24].
3.2. Loss of increase in intestinal glucose absorption by portal
insulin in chronically ethanol-intoxicated rats
In the isolated, jointly perfused intestine and liver of rats
the rate of basal glucose absorption following the ¢rst luminal
glucose bolus (5.5 mmol = 1 g) reached a maximum of
2.6 þ 0.9 Wmol min31 g31 organ weight (Fig. 1A). Total glu-
cose absorption, corresponding to the area under the rate of
glucose absorption vs. time curve (AUC)Uorgan weight
amounted to 251 þ 28 Wmol (Fig. 2). The basal rate of glucose
absorption with ethanol-treated rats reached a maximum of
2.5 þ 1.3 Wmol min31 g31 organ weight (Fig. 1B) correspond-
ing to a total glucose absorption (AUC) of 262 þ 42 Wmol
(Fig. 2). The di¡erence in basal glucose absorption between
control and alcohol-fed rats was statistically not signi¢cant.
In the intestine^liver perfusion of control rats portal insulin
(100 nmol/l), infused into the portal vein, enhanced the rate of
intestinal glucose absorption to a maximum of 14.2 þ 6.7 Wmol
min31 g31 organ weight (Fig. 1A); total glucose absorption
(AUC) was raised from 251 þ 28 Wmol to 856 þ 117 Wmol (Fig.
Table 1
Characterization of control and chronically (6 weeks) ethanol-fed rats
Control standard dieta Ethanol water 20% (v/v)+standard dieta
Energy intake (kJ day31) 190 240*
Body weight at time of starting ethanol diet (g) 264.3 þ 24.6 342.7 þ 12.3*
Body weight at time of experiment (g) 392.3 þ 31.2 383.4 þ 18.3n:s:
Growth (g day31) +3.2 þ 0.3 +0.9 þ 0.1*
Standard diet intake (g kg31 day31) 62.4 þ 5.8 43.0 þ 1.9*
Ethanol intake with water (g kg31 day31) ^ 8.6 þ 0.5
Glucose intake with water (g kg31 day31) ^ 7.8 þ 0.3
Glucose intake with diet (g kg31 day31) 40.6 þ 3.2 28.4 þ 2.5
Blood ethanol concentration (mmol l31) n.d.b 19.4 þ 1.7
Blood glucose concentration (mmol l31) 7.8 þ 0.1 7.1 þ 0.5*
Intestinal weight (g) 7.1 þ 0.2 6.8 þ 0.2n:s:
Liver weight (g) 12.2 þ 0.5 11.8 þ 0.4n:s:
*P6 0.05; n.s., not signi¢cant.
aAd libitum, 12.7 kJ/g.
bNot detectable.
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2). After portal infusion of insulin into the liver of ethanol-
treated rats, the rate of intestinal glucose absorption was
raised only to 5.4 þ 4.2 Wmol min31 g31 organ weight (Fig.
1B), the calculated total glucose absorption (AUC) was ele-
vated slightly from 262 þ 42 Wmol to 333 þ 73 Wmol (Fig. 2).
Thus, portal insulin failed to signi¢cantly enhance glucose
absorption in the perfused intestine and liver from chronically
ethanol-fed rats. The £ow rates in the SMA and CT remained
essentially constant during the entire experiments; they de-
creased only insigni¢cantly towards the end of the perfusion
by 0.23 ml min31 g31 (6.2%) in livers from control rats and by
0.41 ml min31 g31 (11.4%) in livers from ethanol-fed rats,
respectively (Fig. 1, lower panels) which cannot have a¡ected
absorption.
3.3. Loss of increase in intestinal glucose absorption by arterial
carbachol but not by arterial db-cAMP in chronically
ethanol-intoxicated rats
The stimulatory e¡ect of portal insulin on intestinal glucose
absorption is transmitted from the liver to the enterocytes via
cholinergic nerves [4]. The loss of increase in intestinal glucose
absorption by portal insulin following chronic ethanol intox-
ication could be due to an impairment of the hepatoenteral
nerves (including insulin sensing, signal propagating and ef-
fectory nerve cells) and/or of the absorptive enterocytes. The
nerve action can be mimicked by carbachol [4] and the enter-
ocytic glucose absorption can be stimulated by db-cAMP [25^
29]. Therefore, in another series of experiments the in£uence
of chronic ethanol intoxication on the stimulation of glucose absorption by carbachol and by the membrane permeable
cAMP analogue db-cAMP was investigated.
In the isolated perfused intestine and liver of control rats
and ethanol-fed rats of the second series basal glucose absorp-
tion amounted to 271 þ 28 Wmol and 289 þ 62 Wmol. Infusion
of carbachol into the SMA raised total glucose absorption
(AUC) to 796 þ 63 Wmol with control animals (Fig. 3). With
6 weeks alcohol-fed animals, carbachol completely failed to
enhance glucose absorption (Fig. 3). In the same perfused
organ system the infusion of db-cAMP into the SMA caused
a signi¢cant increase in total glucose absorption curve (AUC)
from 271 þ 28 Wmol to 890 þ 31 Wmol with control animals
(Fig. 3). With rats fed alcohol for 6 weeks db-cAMP still
enhanced total glucose absorption (AUC) from 289 þ 62
Wmol to 750 þ 89 Wmol (Fig. 3). Thus, chronic ethanol intox-
ication entirely abrogated the carbachol-induced but not the
cAMP-dependent increase in intestinal glucose absorption, i.e.
it substantially impaired the signaling chain ‘portal insulin^
hepatoenteral nerves^enterocytes^glucose absorption’ but not
the absorptive process in the enterocytes.
4. Discussion
In the present investigation it was demonstrated that in the
joint perfusion of small intestine and liver of rats following
6 weeks of alcohol feeding the stimulatory action of portal
insulin on intestinal glucose absorption was completely abol-
ished and that this abolition was due to an impairment of the
hepatoenteral signal chain involving cholinergic nerves and
not of the absorptive enterocytes.
4.1. Unaltered capacity for intestinal glucose absorption
following chronic ethanol intoxication
Chronic ethanol feeding might have impaired the function
Fig. 1. Impairment of the increase in intestinal glucose absorption
by portal insulin in the isolated, jointly perfused small intestine and
liver of rats following chronic ethanol intoxication. Rats were sub-
jected to chronic alcohol feeding by addition of ethanol to the
drinking water (¢nal concentration 20% (v/v)) in combination with
the standard diet. Small intestine and liver were jointly perfused as
described previously [4,18] with a Krebs^Henseleit bicarbonate bu¡-
er containing 5 mmol/l glucose, 2 mmol/l lactate, 0.2 mmol/l pyru-
vate, 1 mmol/l glutamine, 1% bovine serum albumin and 3% dex-
tran. A glucose bolus (1 g diluted in 1.5 ml 0.9% NaCl) was applied
into the intestinal lumen in the 6th and 31st min. Insulin (100 nmol/
l) was infused into the portal vein from the 21st min onwards. Flow
in the superior mesenteric artery (SMA) was measured by a £ow
meter and in the inferior vena cava (IVC) by fractionated sampling.
Flow in the celiac trunc (CT) was calculated from the di¡erence be-
tween £ow in the IVC and SMA. Values are means þ S.E.M. of the
number of experiments given in parentheses.
Fig. 2. Loss of increase in intestinal glucose absorption by portal in-
sulin in the isolated, jointly perfused intestine and liver of chroni-
cally ethanol-fed rats. Experiments were performed as described in
the legend to Fig. 1. Total absorption of glucose (Wmol) was deter-
mined as the area under the absorption versus time curve (Wmol
min31 g31Umin) multiplied by organ weight (g). Columns show
basal glucose absorption following the ¢rst luminal glucose bolus
(6th min, 1 g diluted in 1.5 ml 0.9% NaCl) and insulin-stimulated
glucose absorption following a second glucose bolus (26th min) with
infusion of insulin (100 nmol/l) into the portal vein. Values are
means þ S.E.M. of 4^5 experiments. *P6 0.05; n.s. = not signi¢cant.
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of the intestinal glucose transporters involved, the apical
SGLT1 and/or the basolateral GLUT2. However, in the iso-
lated, jointly perfused small intestine and liver basal glucose
absorption did not di¡er signi¢cantly in preparations of con-
trol and chronically ethanol-fed rats (Figs. 1^3). These ¢nd-
ings indicated an unaltered capacity of both glucose trans-
porters, the SGLT1 and the GLUT2. Previous studies on
the chronic e¡ects of ethanol on glucose absorption yielded
contradictory results : Following long-term ethanol treatment
glucose absorption in intact segments of the rat small intestine
was found to be increased [30], unaltered [31] or decreased
[32]. In brush-border membrane vesicles prepared from
chronically ethanol-fed rats glucose uptake via the SGLT1
was enhanced [31] ; however, in the same preparation from
guinea pigs the driving force of the SGLT1, the sodium gra-
dient, was decreased [33].
It was shown previously with di¡erent experimental systems
that cAMP acutely stimulated glucose absorption via the
SGLT1 [25^29]. In the present study with the isolated, jointly
perfused small intestine and liver db-cAMP acutely enhanced
glucose absorption in preparations of control and chronically
ethanol-fed rats (Fig. 3). This also indicated that the absorp-
tive capacity via the SGLT1 and GLUT2 of the enterocytes
was unaltered in the chronically ethanol-intoxicated rats.
4.2. Impaired function of the signaling chain involving
hepatoenteral nerves in chronically ethanol-intoxicated rats
The anatomical basis of the hepatoenteral nervous pathway
mediating the increase in intestinal glucose absorption by por-
tal insulin is unknown so far. It must start with the sensing of
insulin in the hepatoportal area. Electrophysiological studies
demonstrated a sensing in the portal vein of the concentra-
tions of glucose [34], glucagon and insulin [35]. Therefore, the
nerves between liver and small intestine could originate in the
hepatoportal area and end in the small intestine, where they
would release acetylcholine to a cell expressing muscarinic
receptors. Since cAMP is the intracellular messenger in the
enterocytes which stimulates glucose absorption [25^29], and
muscarinic receptors are known to decrease cAMP or to in-
crease IP3 but not to elevate cAMP [36], acetylcholine cannot
act directly on the enterocytes but via an additional interven-
ing cell. Since in the chronically ethanol-intoxicated rats arte-
rial cAMP was still able to increase intestinal glucose absorp-
tion (Fig. 3), the absorptive function of the enterocytes was
not impaired. Thus, the loss of the stimulatory e¡ect of portal
insulin and arterial carbachol was due to a functional impair-
ment in the signal chain from the liver to the small intestine.
This signal chain is composed of several steps. Of the di¡erent
single steps, sensing the insulin concentration in the hepato-
portal area by a sensory cell, transmitting the signal to the
small intestine via cholinergic nerves, releasing acetylcholine
to a muscarinic receptor or an intervening cell and forwarding
the signal by the intervening cell, one alone or a combination
of two or all can be compromised in function. At least the last
step was impaired, but the ¢rst and second might also have
been a¡ected. Thus ultimately ethanol intoxication resulted in
a failure of portal insulin to stimulate glucose absorption via
hepatoenteral nerves. This impairment corresponds to a neu-
ropathy, which is a well known complication of chronic alco-
hol abuse in humans [7,8]. A loss of function of the hepatoen-
teral nerves would be in line with a general impairment of
autonomic nerves as found with the thermoregulatory re-
sponse [37], the cardiovascular system [10], the sympathetic
skin response [9] and e¡ectory hepatic nerves [11]. An im-
paired function due to a diabetic neuropathy of these hepa-
toenteral nervous signal chain has also been observed in strep-
tozotocin-diabetic rats [5].
4.3. Possible pathophysiological role of the impairment of the
signaling chain via hepatoenteral nerves in chronic ethanol
intoxication
Ethanol-induced hypoglycemia is a common ¢nding in hu-
mans and in animals under experimental conditions [38^40].
In the postabsorptive state the organism maintains euglycemia
by hepatic gluconeogenesis and glycogenolysis. Hypoglycemia
with chronic ethanol abuse is mainly due to the inhibition by
ethanol of gluconeogenesis [41^43] and of the sympathetic
nerve-dependent glycogenolysis in the liver [11]. In the absorp-
tive phase the organism normally has to handle more glucose
than it actually needs for the supply of glucose-dependent
cells ; part of the glucose o¡ered in excess is used to replenish
the hepatic glycogen reserves [44] and thus prevents a post-
prandial hyperglycemia exceeding the reabsorptive capacity of
the kidney. Since the ethanol-induced impairment of the hep-
atoenteral signal chain would result in a delayed and even
reduced intestinal absorption of ingested glucose, it would
help to prevent a postprandial hyperglycemia. This could con-
tribute to ethanol-induced hypoglycemia only if in the meals
of the alcoholics ethanol replaces glucose to a high extend, so
that glucose intake is smaller than the actual demands. With
heavy drinkers this may often be the case.
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